Loading…
Amedica Corporation agreed to sell its commercial spine business to CTL Medical for total consideration of up to $10 million. CTL Medical will acquire Amedica's portfolio of metal and silicon nitride spine products, inventory, and regulatory clearances. The transaction is expected to close in Q3 2018.
“The transaction makes strategic sense, by monetizing our commercial spine sales organization and allowing Amedica to focus on its core biomaterials and OEM business.”globenewswire.com
Summarized from public sources; check the original articles before acting on it.